Dáil
Written answer
Medicinal Products
Summary
The HSE was asked to provide expenditure figures and identify reimbursed obesity medicines, as it has statutory responsibility for pricing and reimbursement decisions.
3320. Deputy Malcolm Byrne asked the Minister for Health the total expenditure on reimbursable medicines for the management of obesity for each of the years from 2016 to 2025 inclusive under the HSE Medicines Management Programme; and to list the primary drugs that are refunded. [59945/26]